Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chicago, Illinois 60608


Purpose:

Children between 6-17 are evaluated for ADHD and and a blood sample is obtained for DNA extraction. If eligible, they participate in a 4 week, double blind, placebo controlled trial with weekly switches. In randomized order, children receive 18, 36, 54 mg. OROS methylphenidate and placebo. Each week, parent report measures, clinical interviews, and safety assessments are conducted. Hypothesis: Efficacy and adverse events will be dose dependent. Dopamine Transporter Genotype will predict response


Criteria:

Inclusion Criteria: - 6-17 DSM IV criteria for ADHD Parents willing to complete measures Exclusion Criteria: - Mental retardation psychoses seizure disorder


NCT ID:

NCT00663442


Primary Contact:

Principal Investigator
Mark A Stein, Ph.D.
Univesity of Illinois at Chicago


Backup Contact:

N/A


Location Contact:

Chicago, Illinois 60608
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 19, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.